• Merz Inc., of Greensboro, N.C., said it acquired Cuvposa (glycopyrrolate) oral solution, an acetylcholine receptor inhibitor, for pediatric chronic severe drooling associated with neurologic conditions such as cerebral palsy. Financial terms were not disclosed.